Skip to main content
letter
. 2020 May 22;43(8):854–856. doi: 10.1038/s41440-020-0476-3

Fig. 2.

Fig. 2

Downregulation of ACE2 during COVID-19 increases AT1R stimulation, hypokalemia, and lung and cardiovascular injury (FS)